Na Jin

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

W. Wolfgang Fleischhacker, Raymond Sanchez, Pamela Perry et al. · The British Journal of Psychiatry · 2014 · 152 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Aripiprazole for the treatment of pediatric bipolar I disorder: a 30‐week, randomized, placebo‐controlled study

Robert L. Findling, Christoph U. Correll, Margaretta Nyilas et al. · Bipolar Disorders · 2013 · 120 citations

Medicine, Pharmacology, Pharmacotherapy +17

Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration

Arash Raoufinia, Timothy Peters-Strickland, Anna‐Greta Nylander et al. · The International Journal of Neuropsychopharmacology · 2017 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder

Matthew Harlin, Murat Yildirim, Pedro Such et al. · CNS Drugs · 2023 · 36 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome

K. J. Zhu, Fan He, Na Jin et al. · Journal of Clinical Pharmacy and Therapeutics · 2009 · 35 citations

Medicine, Cardiology, Pharmacotherapy +17